Skip to main content
Log in

The prognostic factors of recurrent GCT: a cooperative study by the Eastern Asian Musculoskeletal Oncology Group

  • Original article
  • Published:
Journal of Orthopaedic Science

Abstract

Background

Giant-cell tumor (GCT) of bone is a common primary benign tumor with high local recurrence and potential distant metastasis or malignant transformation. We have investigated the clinical behavior of recurrent GCT of bone in the extremities.

Methods

We retrospectively reviewed 110 patients with recurrent GCTs of bone in the extremities treated by the Eastern Asian Musculoskeletal Oncology Group. The factors that affected the number of recurrences and distant metastasis were analyzed.

Results

The median interval between initial surgery and the first recurrence of GCT was 16 months (2–180 months). All patients received additional surgery for first recurrence. Twenty-five patients had a second recurrence and 6 patients had a third recurrence. The mean interval between the initial surgery and the first recurrence correlated with the eventual number of recurrences—14.1 months for the repeated recurrence groups (two and three recurrences) and 28.3 months for the single recurrence group (p = 0.016). Campanacci grade did not correlate with repeated recurrence (p = 0. 446). The venue of the initial surgery did not correlate with recurrence but did affect preservation of the adjacent joint (chi-squared test; p = 0.046). Campanacci grade II and III also correlated with sacrifice of the adjacent joint (p = 0.020). The incidence of lung metastasis and malignant transformation were 7.5% (8 out of 107 patients) and 2.7% (3 out of 110 patients), respectively. Repeat recurrence was associated with lung metastasis (p = 0.018).

Conclusions

Early local recurrence of GCT is a risk factor for repeat recurrence. Repeat recurrence also correlates with lung metastasis. Recurettage with meticulous adjuvant treatment to completely preclude recurrent lesions is a reasonable method for preserving the adjacent joint. However, a continuous careful follow-up is mandatory.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Dahlin DC. Caldwell lecture. Giant cell tumor of bone: highlights of 407 cases. AJR Am J Roentgenol. 1985;144:955–60.

    PubMed  CAS  Google Scholar 

  2. Eckardt JJ, Grogan TJ. Giant cell tumor of bone. Clin Orthop Relat Res. 1986;204:45–58.

    PubMed  Google Scholar 

  3. Marcove RCA. 17-year review of cryosurgery in the treatment of bone tumors. Clin Orthop Relat Res. 1982;163:231–4.

    PubMed  Google Scholar 

  4. Malawer MM, Dunham W. Cryosurgery and acrylic cementation as surgical adjuncts in the treatment of aggressive (benign) bone tumors. Analysis of 25 patients below the age of 21. Clin Orthop Relat Res. 1991;262:42–57.

    PubMed  Google Scholar 

  5. McDonald DJ, Sim FH, McLeod RA, Dahlin DC. Giant-cell tumor of bone. J Bone Jt Surg Am. 1986;68:235–42.

    CAS  Google Scholar 

  6. Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Jt Surg Am. 1987;69:106–14.

    CAS  Google Scholar 

  7. Capanna R, Fabbri N, Bettelli G. Curettage of giant cell tumor of bone. The effect of surgical technique and adjuvants on local recurrence rate. Chir Organi Mov. 1990;75:206.

    PubMed  CAS  Google Scholar 

  8. O’Donnell RJ, Springfield DS, Motwani HK, Ready JE, Gebhardt MC, Mankin HJ. Recurrence of giant-cell tumors of the long bones after curettage and packing with cement. J Bone Jt Surg Am. 1994;76:1827–33.

    Google Scholar 

  9. Bini SA, Gill K, Johnston JO. Giant cell tumor of bone. Curettage and cement reconstruction. Clin Orthop Relat Res. 1995;321:245–50.

    PubMed  Google Scholar 

  10. Ghert MA, Rizzo M, Harrelson JM, Scully SP. Giant-cell tumor of the appendicular skeleton. Clin Orthop Relat Res. 2002;400:201–10.

    Article  PubMed  Google Scholar 

  11. Ward WG Sr, Li G 3rd. Customized treatment algorithm for giant cell tumor of bone: report of a series. Clin Orthop Relat Res. 2002;397:259–70.

    Article  PubMed  Google Scholar 

  12. Turcotte RE, Wunder JS, Isler MH, Bell RS, Schachar N, Masri BA, Moreau G, Davis AM. Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res. 2002;397:248–58.

    Article  PubMed  Google Scholar 

  13. Goldenberg RR, Campbell CJ, Bonfiglio M. Giant-cell tumor of bone. An analysis of two hundred and eighteen cases. J Bone Jt Surg Am. 1970;52:619–64.

    CAS  Google Scholar 

  14. Larsson SE, Lorentzon R, Boquist L. Giant-cell tumor of bone. A demographic, clinical, and histopathological study of all cases recorded in the Swedish Cancer Registry for the years 1958 through 1968. J Bone Jt Surg Am. 1975;57:167–73.

    CAS  Google Scholar 

  15. Rock MG, Pritchard DJ, Unni KK. Metastases from histologically benign giant-cell tumor of bone. J Bone Jt Surg Am. 1984;66:269–74.

    CAS  Google Scholar 

  16. Kay RM, Eckardt JJ, Seeger LL, Mirra JM, Hak DJ. Pulmonary metastasis of benign giant cell tumor of bone. Six histologically confirmed cases, including one of spontaneous regression. Clin Orthop Relat Res. 1994;302:219–30.

    PubMed  Google Scholar 

  17. Prosser GH, Baloch KG, Tillman RM, Carter SR, Grimer RJ. Does curettage without adjuvant therapy provide low recurrence rates in giant-cell tumors of bone? Clin Orthop Relat Res. 2005;435:211–8.

    Article  PubMed  Google Scholar 

  18. Tubbs WS, Brown LR, Beabout JW, Rock MG, Unni KK. Benign giant-cell tumor of bone with pulmonary metastases: clinical findings and radiologic appearance of metastases in 13 cases. Am J Roentgenol. 1992;158:331–4.

    CAS  Google Scholar 

  19. Vult von Steyern F, Bauer HC, Trovik C, Kivioja A, Bergh P, Holmberg Jorgensen P, Follerås G, Rydholm A. Treatment of local recurrences of giant cell tumour in long bones after curettage and cementing. A Scandinavian Sarcoma Group study. J Bone Jt Surg Br. 2006;88:531–5.

    Article  CAS  Google Scholar 

  20. Balke M, Ahrens H, Streitbuerger A, Koehler G, Winkelmann W, Gosheger G, Hardes J. Treatment options for recurrent giant cell tumors of bone. J Cancer Res Clin Oncol. 2009;135:149–58.

    Article  PubMed  Google Scholar 

  21. Becker WT, Dohle J, Bernd L, Braun A, Cserhati M, Enderle A, Hovy L, Matejovsky Z, Szendroi M, Trieb K, Tunn PU. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. J Bone Jt Surg Am. 2008;90:1060–7.

    Article  Google Scholar 

  22. McGough RL, Rutledge J, Lewis VO, Lin PP, Yasko AW. Impact severity of local recurrence in giant cell tumor of bone. Clin Orthop Relat Res. 2005;438:116–22.

    Article  PubMed  Google Scholar 

  23. Campanacci M. Giant-cell tumor and chondrosarcomas: grading, treatment and results (studies of 209 and 131 cases). Recent Results Cancer Res. 1976;54:257–61.

    PubMed  Google Scholar 

  24. Rock M. Curettage of giant cell tumor of bone. Factors influencing local recurrences and metastasis. Chir Organi Mov. 1990;75:204–5.

    PubMed  CAS  Google Scholar 

  25. Tyler W, Barrett T, Frassica F, McCarthy E. Skin metastasis from conventional giant cell tumor of bone: conceptual significance. Skeletal Radiol. 2002;31:166–70.

    Article  PubMed  CAS  Google Scholar 

  26. Present DA, Bertoni F, Springfield D, Braylan R, Enneking WF. Giant cell tumor of bone with pulmonary and lymph node metastases. A case report. Clin Orthop Relat Res. 1986;209:286–91.

    PubMed  Google Scholar 

  27. Brien EW, Mirra JM, Kessler S, Suen M, Ho JK, Yang WT. Benign giant cell tumor of bone with osteosarcomatous transformation (“dedifferentiated” primary malignant GCT): report of two cases. Skeletal Radiol. 1997;26:246–55.

    Article  PubMed  CAS  Google Scholar 

  28. Bertoni F, Bacchini P, Staals EL. Malignancy in giant cell tumor of bone. Cancer. 2003;97:2520–9.

    Article  PubMed  Google Scholar 

  29. Sakkers RJ, van der Heul RO, Kroon HM, Taminiau AH, Hogendoorn PC. Late malignant transformation of a benign giant-cell tumor of bone. A case report. J Bone Jt Surg Am. 1997;79:259–62.

    CAS  Google Scholar 

Download references

Acknowledgments

The authors greatly appreciate Patrick P. Lin MD, for his valuable criticism and advice.

Conflict of interest

The authors indicate no potential conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroyuki Tsuchiya.

About this article

Cite this article

Takeuchi, A., Tsuchiya, H., Niu, X. et al. The prognostic factors of recurrent GCT: a cooperative study by the Eastern Asian Musculoskeletal Oncology Group. J Orthop Sci 16, 196–202 (2011). https://doi.org/10.1007/s00776-011-0030-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00776-011-0030-x

Keywords

Navigation